In:
Cancer, Wiley, Vol. 121, No. S17 ( 2015-09), p. 3113-3121
Abstract:
In this study, the serum levels of 4 biomarkers (progastrin‐releasing peptide, carcinoembryonic antigen, squamous cell carcinoma antigen, and cytokeratin 19 fragment) are determined for 153 patients with a high risk of lung cancer (including 89 control subjects). This panel increases the diagnostic specificity for high‐risk subjects, and auxiliary to a CT scan, it increases the sensitivity for patients with lung cancer.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v121.S17
Language:
English
Publisher:
Wiley
Publication Date:
2015
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink